Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Rad Laboratories (BIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Bio-Rad Banks on Solid Global Scenario, Competition Rife

Bio-Rad (BIO) delivers robust performance, primarily in North America, China and the Asia-Pacific region.

ABT : 62.91 (-0.08%)
TMO : 215.80 (-0.35%)
BIO : 303.88 (+0.06%)
ISRG : 490.49 (-1.02%)
Bio-Rad to Present at Jefferies 2018 Global Healthcare Conference on June 5

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Christine...

BIO : 303.88 (+0.06%)
Bio-Rad (BIO) Up 13.5% in 3 Weeks Post Solid Q1 Earnings

Bio-Rad (BIO) Q1 results reflect impressive segmental sales and solid performance across all geographies.

GHDX : 49.59 (+0.65%)
VAR : 122.17 (-0.92%)
ABMD : 443.58 (+0.66%)
BIO : 303.88 (+0.06%)
After Yesterday's Rally of 2.78% Shares Could Potentially Pullback

Bio-Rad Labs-A (NYSE:BIO) traded in a range yesterday that spanned from a low of $283.51 to a high of $293.43. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of...

BIO : 303.88 (+0.06%)
Bio-Rad Labs-A is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (BIO , LMNX , ILMN , NEO , A )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

ILMN : 288.75 (-0.49%)
LMNX : 30.12 (-0.89%)
BIO : 303.88 (+0.06%)
Medical Product Stocks May 8 Earnings List: HSIC, PEN & More

An important component of the broader Medical sector, the Medical Product space consistently grabs attention owing to a string of upsides.

HSIC : 73.29 (+0.56%)
PEN : 155.05 (-1.18%)
BIO : 303.88 (+0.06%)
HAE : 91.13 (-4.83%)
PRGO : 75.11 (+0.37%)
3 Reasons Why You Should Invest in Baxter International Now

Baxter (BAX) gains ground on strategic buyouts and a raised guidance for 2018.

BAX : 75.22 (-0.25%)
BIO : 303.88 (+0.06%)
EVHC : 44.67 (-0.25%)
FMS : 51.31 (-0.27%)
Integra LifeSciences (IART) Tops on Q1 Earnings, '18 View Up

Integra LifeSciences' (IART) revenue growth was primarily driven by high organic revenues, successful progress with Codman integration and progress with the channel expansion strategy.

ABAX : 83.26 (-0.13%)
RMD : 105.80 (-0.90%)
IART : 67.23 (+0.28%)
BIO : 303.88 (+0.06%)
LabCorp (LH) Beats on Q1 Earnings, Revenues, Lifts '18 View

LabCorp's (LH) Diagnostics business was solid on the back of increasing acquisitions, organic volume expansion and a favorable foreign exchange scenario.

ABAX : 83.26 (-0.13%)
RMD : 105.80 (-0.90%)
BIO : 303.88 (+0.06%)
LH : 189.41 (+0.81%)
Thermo Fisher (TMO) Q1 Earnings Beat Estimates, '18 View Up

Thermo Fisher's (TMO) performance in Q1 benefits from a series of product launches alongside a major progress in precision medicine initiatives.

ABAX : 83.26 (-0.13%)
TMO : 215.80 (-0.35%)
RMD : 105.80 (-0.90%)
BIO : 303.88 (+0.06%)
Illumina (ILMN) Beats on Q1 Earnings, Lifts '18 Guidance

Illumina's (ILMN) collaboration with Bristol-Myers Squibb and Loxo Oncology are likely to yield results in the near term.

ABAX : 83.26 (-0.13%)
ILMN : 288.75 (-0.49%)
RMD : 105.80 (-0.90%)
BIO : 303.88 (+0.06%)
Edwards Lifesciences (EW) Q1 Earnings Beat, Revenues Miss

Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q1.

EW : 152.51 (+0.63%)
ABAX : 83.26 (-0.13%)
RMD : 105.80 (-0.90%)
BIO : 303.88 (+0.06%)
Boston Scientific (BSX) Beats on Q1 Earnings, Lifts '18 View

Boston Scientific (BSX) registers steady growth across all business lines and geographies in Q1.

BSX : 32.96 (+1.38%)
ABAX : 83.26 (-0.13%)
RMD : 105.80 (-0.90%)
BIO : 303.88 (+0.06%)
Here's Why You Should Invest in Integer Holdings Right Now

Integer Holdings' (ITGR) unswerving focus on customer relationship, cost reduction and burgeoning financial performance are key catalysts.

ITGR : 64.95 (+0.23%)
ABMD : 443.58 (+0.66%)
MYGN : 39.42 (+1.52%)
BIO : 303.88 (+0.06%)
Edwards Lifesciences' (EW) THVT Likely to Drive Q1 Earnings

Edwards Lifesciences (EW) is expected to gain from strength in THVT on continued therapy adoption across all geographies in Q1.

EW : 152.51 (+0.63%)
ABMD : 443.58 (+0.66%)
BIO : 303.88 (+0.06%)
LH : 189.41 (+0.81%)
Here's Why You Should Invest in Stryker (SYK) Right Now

Stryker (SYK) gains from stellar performance of the flagship Mako platform; guidance solid.

ITGR : 64.95 (+0.23%)
SYK : 168.38 (-0.22%)
BIO : 303.88 (+0.06%)
EVHC : 44.67 (-0.25%)
Chemed (CHE) Beats on Q1 Earnings & Revenues, Retains View

Chemed (CHE) rides on strong contributions from the Roto-Rooter and VITAS businesses in Q1.

CHE : 323.68 (-0.91%)
ABAX : 83.26 (-0.13%)
BIO : 303.88 (+0.06%)
LH : 189.41 (+0.81%)
Quest Diagnostics (DGX) Q1 Earnings Meet, Guidance Intact

Quest Diagnostics' (DGX) year-over-year revenue improvement in Q1 came on the back of successful execution of its two-point strategy of accelerating growth and driving operational excellence.

DGX : 111.31 (+0.33%)
ABAX : 83.26 (-0.13%)
BIO : 303.88 (+0.06%)
ALGN : 362.66 (-0.99%)
Bio-Rad to Report First-Quarter 2018 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2018 on Tuesday,...

BIO : 303.88 (+0.06%)
Abbott (ABT) Q1 Earnings & Revenues Top, '18 View Retained

Abbott (ABT) continues to gain from a strong and consistent EPD as well as a robust Medical Devices performance.

ABT : 62.91 (-0.08%)
ABAX : 83.26 (-0.13%)
BIO : 303.88 (+0.06%)
ALGN : 362.66 (-0.99%)

Van Meerten Stock Picks

5 Great Large Caps
This morning I wanted to find 5 Large Cap stocks that had performed well over the last year and still appeared to have some juice left in them.
ABMD +2.93 , NFLX -0.89 , VLO -1.64 , RL +0.62 , ALGN -3.61
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed with most nearby contracts 1 to 2 cents lower on Friday, despite showing gains at midday. Front month July lost 4.37% on the week. December fell to within 1 1/4 cents of the life of contract low in the overnight session. Managed m...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar